Alpha Cognition Inc (ACOG)

Alpha Cognition Inc (ACOG) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $192M; returns 1 day +0.4%, 1 week +1.8%, 1 year +19.3%.

Alpha Cognition Inc. (ACOG) is a commercial-stage biopharmaceutical company focused on developing treatments for neurodegenerative diseases, particularly Alzheimer's disease and cognitive impairment related to mild traumatic brain injury.

Groups ACOG belongs to

• Biopharmaceutical
• Alzheimer's Disease
• Commercial Stage
• Commercial Stage Biotech
• Healthcare
• Pharmaceuticals
• CNS Disorders
• Biotechnology
• Neuroscience
• Neurological Disorders
• Life Sciences
• Post-Acute Care
• Aging Population Needs

ACOG financial model: income statement, cash flow and balance sheet